Skip to main content
SupplementScience
Indole-3-Carbinol (I3C) supplement
Phytochemical / Estrogen Metabolism

Indole-3-Carbinol (I3C): Benefits, Dosage, Forms & Research

Phytochemical / Estrogen Metabolism

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

TL;DR — Quick Answer

I3C is a precursor to DIM found in cruciferous vegetables. At 200-400mg daily, it shifts estrogen metabolism toward the 2-hydroxyestrone pathway and has shown benefit for HPV-related recurrent respiratory papillomatosis. DIM supplements are generally preferred over I3C for estrogen modulation due to more predictable dosing and fewer GI side effects.

Key Facts

What it is
A glucosinolate-derived compound from cruciferous vegetables that converts to DIM and other metabolites in the stomach
Primary benefits
  • Shifts estrogen metabolism toward 2-hydroxylation
  • May benefit HPV-related papillomatosis
  • Induces CYP1A1 detoxification enzyme activity
  • Precursor to the bioactive metabolite DIM
Typical dosage
200-400mg I3C daily
Evidence level
Moderate
Safety profile
Generally Safe

What the Research Says

I3C research spans estrogen metabolism, HPV-related conditions, and cancer prevention. Rosen et al. (1998) published a key study on recurrent respiratory papillomatosis showing that 200mg of I3C daily stopped papilloma growth in a third of patients. Bell et al. (2000) studied 30 women with CIN II-III and found that 200mg of I3C daily led to CIN regression in 50% of participants over 12 weeks. For estrogen metabolism, multiple studies confirm that I3C shifts the 2:16α-OHE1 ratio, though the effect is more variable than with DIM due to pH-dependent conversion kinetics. The 2017 consensus in the field has generally shifted to recommending DIM over I3C for estrogen modulation, as DIM bypasses the variable stomach conversion and provides a more consistent dose of the primary active metabolite.

Benefits of Indole-3-Carbinol (I3C)

  • Estrogen metabolism — I3C at 300-400mg daily has been shown to significantly increase the urinary 2:16α-OHE1 ratio, indicating enhanced 2-hydroxylation of estrogen; this shift is associated with potentially reduced proliferative signaling
  • Recurrent respiratory papillomatosis — Rosen et al. (1998) found that I3C at 200mg daily stopped or reduced papilloma growth in 33% of patients with HPV-related RRP, one of the few clinical applications with direct evidence
  • CYP1A1 induction — I3C and its metabolites are potent inducers of CYP1A1, a Phase I detoxification enzyme involved in estrogen 2-hydroxylation and xenobiotic metabolism
  • Cervical health — Bell et al. (2000) studied I3C for cervical intraepithelial neoplasia (CIN) and found regression in 50% of patients taking 200mg daily, compared to none in the placebo group
Did you know?

I3C research spans estrogen metabolism, HPV-related conditions, and cancer prevention.

Forms of Indole-3-Carbinol (I3C)

FormBioavailabilityBest For
I3C CapsulesModerate (variable stomach pH-dependent conversion)HPV-related conditions — most clinical studies used I3C directly; for estrogen modulation, DIM is often preferred
Cruciferous Vegetable ExtractLow-ModerateBroad cruciferous benefits — provides I3C alongside other glucosinolates (sulforaphane precursors)

Dosage Recommendations

General recommendation: 200-400mg I3C daily in divided doses

Timing: With meals in divided doses (e.g., 200mg twice daily); stomach acid is needed for conversion to active metabolites • Take with food for best absorption.

Dosage by Condition

ConditionRecommended DoseEvidence
Estrogen metabolism modulation200-400mg daily in divided dosesModerate
HPV-related papillomatosis200mg dailyModerate
Cervical health (CIN)200-400mg dailyEmerging

Upper limit: 400mg daily; higher doses may cause GI side effects and unpredictable metabolite formation

Side Effects and Safety

Safety profile: Generally Safe

Potential Side Effects

  • GI symptoms — nausea, gas, bloating, and diarrhea (more common than with DIM due to stomach acid reactions)
  • Skin rash (uncommon)
  • Unsteadiness or balance issues at high doses (rare, reported in one trial)
  • Variable metabolite production — individual stomach pH differences create inconsistent conversion profiles

Drug & Supplement Interactions

  • CYP1A2 substrates — I3C strongly induces CYP1A2; may reduce levels of caffeine, theophylline, clozapine, and other 1A2 substrates
  • Estrogen-sensitive medications — modulates estrogen metabolism; consult oncologist if on hormonal therapies
  • Antacids and proton pump inhibitors — reduced stomach acid impairs I3C conversion to active metabolites; may reduce efficacy
  • Hormonal contraceptives — theoretical interaction with estrogen metabolism
Check Indole-3-Carbinol (I3C) interactions with other supplements →
BenefitsDosage GuideSide EffectsTypes & FormsResearchFAQ

Related Supplements

DIM (Diindolylmethane)Calcium D-GlucarateVitex (Chasteberry)

Frequently Asked Questions

Should I take I3C or DIM for estrogen balance?

For most people, DIM is the better choice for estrogen metabolism support. I3C must be converted to DIM (and other metabolites) in the stomach, and this conversion is variable depending on stomach pH, meal composition, and individual factors. DIM supplements deliver the active metabolite directly, providing more predictable and consistent effects. The main exception is HPV-related conditions, where the clinical studies specifically used I3C, and other I3C metabolites (not just DIM) may contribute to the therapeutic effect.

How much broccoli would I need to eat to get a therapeutic dose of I3C?

You would need to eat approximately 300-500g (about 2-3 cups) of raw broccoli daily to approach the 200-400mg I3C dose used in clinical studies. Cooking reduces glucosinolate content by 30-60% depending on method. While regular cruciferous vegetable consumption is beneficial for health, achieving therapeutic I3C levels through diet alone is impractical for most people, which is why supplements exist.

Can I3C help with HPV?

I3C has shown specific promise for HPV-related conditions. Rosen et al. (1998) found that 200mg daily helped control recurrent respiratory papillomatosis (RRP). Bell et al. (2000) demonstrated CIN regression in women taking I3C. The mechanism likely involves both immune modulation and direct effects on HPV-infected cell proliferation. However, I3C is not a treatment for HPV infection itself — it may help manage HPV-related cellular changes. Always work with your healthcare provider for HPV-related conditions.

References

  1. (). Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. Journal of Voice.
  2. (). Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecologic Oncology. DOI
  3. (). Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane. Cancer Epidemiology, Biomarkers & Prevention. DOI